These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy. Giampietri A; Bonmassar A; Puccetti P; Circolo A; Goldin A; Bonmassar E Cancer Res; 1981 Feb; 41(2):681-7. PubMed ID: 7448813 [TBL] [Abstract][Full Text] [Related]
47. Effects of adoptive immune transfers on murine leukemia virus-infection of rats. Hein A; Czub S; Xiao LX; Schwender S; Dörries R; Czub M Virology; 1995 Aug; 211(2):408-17. PubMed ID: 7645245 [TBL] [Abstract][Full Text] [Related]
48. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression. Ahlstedt S Scand J Infect Dis Suppl; 1980; Suppl 24():216-9. PubMed ID: 7010558 [TBL] [Abstract][Full Text] [Related]
49. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice. Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370 [TBL] [Abstract][Full Text] [Related]
50. Pathogenesis of age dependent paralysis by a temperature sensitive mutant (tsl) of Moloney murine leukemia virus-TB. Prasad G; Wong PK Indian J Exp Biol; 1992 Sep; 30(9):814-8. PubMed ID: 1478716 [TBL] [Abstract][Full Text] [Related]
51. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells. Hinkula J; Walther-Jallow L; Laurén A; Mäkitalo B; Oberg M; Wahren B; Fenyö EM; Spetz AL Vaccine; 2009 Oct; 27(46):6424-31. PubMed ID: 19549607 [TBL] [Abstract][Full Text] [Related]
52. Genetic control of in vitro NK-activity and in vivo resistance to tumors. Kärre K; Klein GO; Kiessling R; Klein G Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339 [TBL] [Abstract][Full Text] [Related]
53. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain. Kitagawa M; Aizawa S; Kamisaku H; Sado T; Ikeda H; Hirokawa K Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289 [TBL] [Abstract][Full Text] [Related]
54. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice. Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120 [TBL] [Abstract][Full Text] [Related]
55. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity. Slos P; De Meyer M; Leroy P; Rousseau C; Acres B Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452 [TBL] [Abstract][Full Text] [Related]
56. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations. Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773 [TBL] [Abstract][Full Text] [Related]
57. [Inhibition of the effect of immunocytotherapy in leukemia in mice under stress and the possibilities of its withdrawal]. Sukhikh GT Biull Eksp Biol Med; 1984 Dec; 98(12):694-6. PubMed ID: 6542442 [TBL] [Abstract][Full Text] [Related]
58. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors. Cheever MA; Greenberg PD; Fefer A J Immunol; 1980 Aug; 125(2):711-4. PubMed ID: 6156213 [TBL] [Abstract][Full Text] [Related]
59. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects. Fodstad O; Hansen CT; Cannon GB; Statham CN; Lichtenstein GR; Boyd MR Cancer Res; 1984 Oct; 44(10):4403-8. PubMed ID: 6467201 [TBL] [Abstract][Full Text] [Related]
60. Hematopoietic stem cells in Friend murine leukemia virus-infected mice undergoing chemotherapy: effects of 5-FU. Seidel HJ; Kreja L Cancer Treat Rep; 1982 Nov; 66(11):1949-56. PubMed ID: 7139639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]